TORONTO, Oct. 25 /CNW/ - Amorfix Life Sciences (TSX: AMF), a company focused on diagnostics and treatments for brain-wasting diseases, today announced the results from the testing of a blinded panel of blood samples from scrapie infected sheep. Amorfix correctly identified 18 out of 20 individual sheep blood samples in a blinded panel provided by an independent third-party laboratory, the Caine Veterinary Teaching Center, University of Idaho.
